News
Cold Chain Technologies Announces Further Global Expansion Into Latin America
Cold Chain Technologies, an ISO 9001:2015 certified global leader with more than 50 years developing and delivering smart solutions that protect the integrity of temperature-sensitive products, announced an extensive expansion into Latin America. The company has been operating out...
News
Andaman7 delivers step change strategy to global debate on digital health opportunities for Africa
With Africa emerging as the new breeding ground for innovative digital health solutions, an expert panel of global development and digital health leaders, including Vincent Keunen, Founder and CEO of Belgian American ehealth company Andaman7, will deliver a webinar...
News
Trialbee and uMotif Simplify and Expand Patient Access to Global Clinical Trials
The increasing need for speed and efficiency in clinical research has created more urgency to streamline and simplify the patient journey. Trialbee, a patient matching and enrolment platform, and uMotif, a patient-centric data capture provider, are partnering to improve...
News
Exscientia Acquires Personalised Medicine AI Pioneer Allcyte
Exscientia, a clinical stage pharmatech company, has entered into a binding agreement to acquire Allcyte, a leader in artificial intelligence (AI) based precision medicine. The combination expands Exscientia’s translational capabilities by enabling high content evaluation of individual patient biology...
News
Ocugen Secures Manufacturing Partnership for US Production of COVID-19 Vaccine Candidate, COVAXIN
Ocugen, Inc., a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, announced that it has entered into an agreement with Jubilant HollisterStier of Spokane,...
News
Moderna and Magenta Partner to Distribute Moderna’s COVID-19 Vaccine and Updated Variant Booster Candidates in UAE
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Magenta Investments, a leading pharmaceutical and healthcare company that is part of an investment and industrial conglomerate in the United Arab Emirates (UAE), announced a new...
News
A world market leader from the Basel region – Bachem celebrates 50 years of company history
Bachem was founded in 1971 by the entrepreneur Peter Grogg. Over the course of half a century Bachem has become a global leader in the development and production of peptides, important ingredients for a range of vital medicines that...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read